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Glucose stimulated insulin secretion (GSIS)Glucose intolerance in C57Bl/6 mice has been associated with mutations in the nicotinamide nucleotide
transhydrogenase (Nnt) gene. It has been proposed that the absence of NNT from mitochondria leads to
increased mitochondrial reactive oxygen species production and subsequent activation of uncoupling protein
2 (UCP2). Activation of UCP2 has been suggested to uncouple electron transport from ATP synthesis in
pancreatic beta cell mitochondria thereby decreasing glucose tolerance due to decreased insulin secretion
through lower ATP/ADP ratios. The hypothesis tested in this paper is that UCP2 function is required for the
dysregulation of glucose homeostasis observed in NNT ablated mice. Single and double Nnt and Ucp2
knockout mouse lines were used to measure glucose tolerance, whole animal energy balance and
biochemical characteristics of mitochondrial uncoupling. As expected, glucose tolerance was diminished in
mice lacking NNT. This was independent of UCP2 as it was observed either in the presence or absence of
UCP2. The range of metabolic parameters examined in the mice and the proton conductance of isolated
mitochondria remained unaltered in this double NNT and UCP2 knockout model. Ablation of UCP2 did not
itself affect glucose tolerance and therefore previous observations of increased glucose tolerance of mice
lacking UCP2 were not conﬁrmed. We conclude that the decreased glucose tolerance in Nnt knockout mice
observed in our experiments does not require UCP2.© 2009 Elsevier B.V. Open access under CC BY license.1. Introduction
Uncoupling protein 2 (UCP2) is a member of a family of mitochon-
drial innermembrane uncoupling proteins that also includesUCP1, UCP3
and the adenine nucleotide translocase. All these proteins are proposed
to share an ancestral function similar to that of UCP1 which uncouples
ATP synthesis from substrate oxidation in brown fat by catalysing a leak
of pumped protons back into the mitochondrial matrix. The resultant
dissipation of themitochondrial protonmotive force produces heat at the
expense of ATP production [1,2]. Unlike UCP1, the substantially lower
levels of the other uncoupling proteins mean it is unlikely that they
produce a physiologically signiﬁcant amountof heat [3]. Inmitochondria
isolated from a variety of tissues and cell lines, uncoupling protein
activity is increased following exposure to fatty acids [4–7], superoxideimal Monitoring System; GSIS,
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P+, Triphenylmethylphospho-
nt of Cell and Developmental
n WC1E 6BT, UK. Tel.: +44 20
vato, CA 94945, USA.
 license.[8], reactive oxygen species (ROS) derivatives such as hydroxynonenal,
and other reactive alkenals [9,10]. This uncoupling activity can be
inhibited by purine nucleoside di- or triphosphates [7,11], carboxy-
atractylate or bongkrekate [11,12]. The uncoupling activity of UCP1 has
long been identiﬁed as the cause of heat production in the brown fat of
neonates and small mammals [2]. The physiological function of other
proteins in the family, however, remains controversial — proposals
includeprotection againstmitochondrial ROSproduction [13–16], export
of fatty acids from the mitochondrial matrix [17–19], and regulation of
insulin secretion in pancreatic beta cells [20–27].
In pancreatic beta cells, the release of insulin is tightly coupled to the
cellular ATP/ADP ratio. There is growing evidence that UCP2 is a
negative regulator of glucose stimulated insulin secretion (GSIS) [20–
27]. Themost compelling observations are that GSIS is improved inUcp2
ablated mice [21] or following UCP2 knockdown in the pancreatic beta
cell model, INS-1E [27]. Speculation has therefore grown as to the
physiological function of UCP2 in the pancreatic beta cell [28]. One
theory is that the presence of UCP2 in mitochondria is required to limit
damagingROSproduction and the subsequent beta cell dysfunction that
would arise. This is supported by data showing higher mitochondrial
membrane potential and elevated ROS levels in isolated pancreatic beta
cells from Ucp2 ablated mice compared to WT controls [24]. However,
the elevation of ROS in UCP2-ablated pancreatic beta cells did not affect
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lead to loss of pancreatic beta cell mass [24]. Other theories suggest that
UCP2 is directly involved in the physiological attenuation of GSIS by
other effectors such as fatty acids [29].
Nicotinamide nucleotide transhydrogenase (NNT) is a ubiquitous
mitochondrial inner membrane protein. When the mitochondrial
membrane potential is high, NNT couples proton translocation to a
redox reaction reducing mitochondrial NADP+ while oxidising NADH
[30–32]. NNT ablation has been suggested to be the main cause of the
glucose intolerant phenotype of certain C57Bl/6J strain mice, which
carry a mutation in the Nnt gene [33–35]. In support of this position,
ablation of Nnt in a non-C57Bl/6J background also results in mice that
are glucose intolerant and have decreased plasma insulin [33].
Pancreatic islets from Nnt knockout (NntKO) mice have a normal
response to the potassium channel blocker tolbutamide, implying that
the regulation of insulin secretion downstream of the KATP channel is
normal. Their low beta cell ATP content following stimulation with
20 mM glucose suggests that NNT may impair insulin secretion via a
diminished ATP/ADP ratio. There is evidence that NNT is involved in the
detoxiﬁcation of reactive oxygen species via themaintenance of a highly
reduced glutathione pool through the NADPH-dependent glutathione
reductase [36]. Indeed, ablation of NNT in Caenorhabditis elegans results
in increased sensitivity to oxidative stress [37]. The NntKO glucose
intolerant phenotype is proposed to be mediated via mitochondrial
glutathione oxidation and elevated ROS leading to activation of UCP2,
and the partial uncoupling of mitochondrial ADP phosphorylation from
substrate oxidation [33], an idea also championed by others [38] (Fig.1).
The aim of this study was to test the hypothesis that glucose
intolerance in NntKO mice is mediated wholly or partly by UCP2. We
looked for epistasis in double NNT and UCP2 knockout animals. If the
hypothesis is correct, the effect of NNT knockout on glucose tolerance
should disappear or decrease on a UCP2-null background.
2. Materials and methods
2.1. Generation of double NNT and UCP2 knockout mouse lines
Experiments were performed in accordance with regulations
speciﬁed by the National Institutes of Health ‘Principles of LaboratoryFig. 1. Hypothesised mechanism of dysregulation of glucose homeostasis by NNT and UCP2
mitochondrial matrix is dependent upon the reduced glutathione pool (GSH). Re-reduction
suggests that NNT is involved in the detoxiﬁcation of O2U− via the maintenance of a hig
Inactivation of NNT is proposed to cause build up of harmful O2U−, activation of UCP2 and diss
F1Fo-ATP synthase. Activation of a proton leak through UCP2 has been shown to decrease thAnimal Care, 1985 Revised Version’ and following U.K. Home Ofﬁce
‘Guidelines for the Care and Use of Laboratory Animals’. Male and
female mice were housed at 21±2 °C and 57±5% humidity in a 12 h
light/12 h dark cycle, with standard laboratory chow and water ad
libitum. Ucp2−/− (termed Ucp2KO) [21] mice (on a mixed 129/Sv and
C57Bl/6 strain, therefore Nnt+/−) and Nnt−/− (termed NntKO) mice
(pure C57Bl/6 strain) were crossed to generate mice heterozygous for
each genotype (Ucp2+/−, Nnt+/−). Experiments using a mixed
background strain may introduce noise into the data but the test for
epistasis remains valid if the NntKO glucose intolerant phenotype is
present. These heterozygous founders were then used to generate the
four littermate genotypes (wild-type (WT), Ucp2KO, NntKO and
Ucp2KO/NntKO) used in the following experiments at 3–5 months of
age. Genotype was conﬁrmed by PCR analysis and by western blotting
of liver, kidney or pancreas mitochondria.2.2. Genomic PCR and immunoblotting analysis
PCR analysis of the Ucp2WT and Ucp2KO genomic locus was as
described [21]. Primers were designed to detect the naturally
occurring Nnt mutation found in some lines of C57Bl/6 mice as
shown (Fig. 2b). TheWT locus was identiﬁed using a sense primer (5′-
ATGGGAGGGCATTTTTATCC-3′) in exon 12 and antisense primer (5′-
CCAGAAAACCACCTTACCGA-3′) in intron 12. The NntKO locus was
identiﬁed with a sense primer in intron 7, 5′ of the deletion event (5′-
CTAAAACACATGCCCCGTCT-3′) and the antisense primer from intron
12. UCP2 and NNT proteins were detected as described in [27] and [33]
respectively.2.3. Glucose tolerance tests
Following overnight fasting, blood glucose levels were assessed
using a glucometer (OneTouch, Lifescan, Milpitas, CA) prior to and
then 10, 20, 30, 60, 120 and 180 min after i.p. injection of a bolus of
glucose (1 g/kg). 13 male and 18 female, age matched, sibling paired
mice were tested (total 31 mice) per group. Student's t-test was used
to assess differences in blood glucose at given time points.. Detoxiﬁcation of superoxide (O2U−) produced by the electron transport chain in the
of glutathione disulﬁde (GSSG) is in turn dependent on the reduced NADPH. Evidence
hly reduced glutathione pool through the NADPH-dependent glutathione reductase.
ipation of the protonmotive force generated by the electron transport chain to drive the
e cellular ATP/ADP ratios needed to drive insulin secretion.
Fig. 2. Generation of transgenic animals. Gene structure (exonic DNA — grey bars; non-coding DNA — black line) of the naturally occurring deletion mutation of the Nnt locus in
C57Bl/6 mice is shown (a) and was assessed by PCR analysis (b) using the primers (arrows) indicated in (a). Ablation of the Ucp2 gene locus according to [21] was also assessed by
PCR using primers described therein (b). Western analyses of isolated mitochondria were used to detect UCP2 in pancreas (c) and NNT in liver (d).
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Oxygen inhalation, carbon dioxide expiration and food and water
intake were measured using an eight-chamber open-circuit oxygen-
monitoring system controlled by CLAMS (Comprehensive Laboratory
Animal Monitoring System; Columbus Instruments, http://www.
colinst.com). Mice (sibling paired males aged 3–5 months) were
housed individually in specially built plexiglass cages and were
acclimatized for 72 h before data collection. Locomotor activity was
simultaneously evaluated using an eight-cage rack OPTO-M3 Sensor
system (Columbus Instruments) with measurements taken every5 min throughout the dark and light cycles. ANOVA was used to test
for differences between groups.
2.5. Proton leak kinetics
Proton leak rate across the mitochondrial inner membrane is
directly proportional to the oxygen consumption rate measured in the
presence of oligomycin to inhibit ATP synthesis [39]. The rate of proton
leak is dependent upon its driving force, protonmotive force
(measured as mitochondrial inner membrane potential in the
presence of nigericin to convert pH gradients into electrical gradients).
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simultaneously using electrodes sensitive to oxygen or themembrane-
potential-dependent probe, triphenylmethylphosphonium (TPMP+).
Mitochondria were isolated from the kidneys of 4 mice per group
as described [39]. Proton leak kinetics were measured as described
[11] with a TPMP+ binding correction assumed to be 0.35 (μl/mg
protein)−1. The time between energisation of mitochondria with
succinate and titration of membrane potential with malonate was
1.5 min. Respiration rates (by linear interpolation between ﬂanking
points)were calculated at the highestmembrane potential common to
all conditions on a given day. ANOVAwas used to test for differences in
these respiration rates.
3. Results
3.1. Generation of a double NNT and UCP2 knockout model of glucose
homeostasis
Mutation of the Nnt gene locus in C57Bl/6J mice was characterized
by a 5 exon deletion (Fig. 2a) that leads to ablation of the protein as
judged by western blot (Fig. 2d). Ucp2KO mice (a kind gift from
Professor Bradford Lowell [21]) were crossed with C57Bl/6J (NntKO)
mice to generate heterozygous founders. Heterozygote matings were
then set up to generate sibling paired mice of the following genotypesFig. 3. Glucose tolerance tests. I.p. glucose tolerance tests were performed in the double NNT
SEM of experiments performed on n=31 (13 male, 18 female) per group. Differences wereof the double NNT and UCP2 knockout model; WT, Ucp2KO, NntKO
and Ucp2KO/NntKO. The genotypes of individual mice were deter-
mined by PCR (Fig. 2b) and ablation of UCP2 or NNT protein was
conﬁrmed by western analysis (Fig. 2c and d).
3.2. Glucose homeostasis in the double NNT and UCP2 knockout model
The double NNT and UCP2 knockout model was used to assess the
role of UCP2 in the glucose dysregulation phenotype seen upon
ablation of Nnt [33]. Following overnight fasting, mice were injected i.
p. with 1 g/kg glucose. Plasma glucose was then measured over a
period of 3 h. As previously observed [33,35], ablation of Nnt alone led
to a signiﬁcant decrease in glucose uptake in the periphery when
compared to WT mice (Fig. 3a), conﬁrming the published effect of
NNT ablation on glucose tolerance.
We were not able to replicate the improved glucose tolerance
observed by Zhang et al. [21] upon ablation of UCP2 in an NntWT
background (Fig. 3b). The improvement of glucose handling seen in
Ucp2KO mice [21] was performed on a mixed C57Bl/6×129/Sv
background. Although not all C57Bl/6 strains harbour the Nnt
mutation, it is possible that the mice in [21] were at least
heterozygous for mutation of Nnt. However, Fig. 3c shows that, in
our hands, UCP2 ablation did not improve glucose tolerance in either
NntWT or NntKO mice.and UCP2 knockout model following overnight fasting (a–d). These results are means±
assessed by unpaired Student's t-test: ⁎pb0.05, ⁎⁎pb0.02, ⁎⁎⁎pb0.005.
Table 1
Whole animal measurements are not signiﬁcantly different between genotypes.










WT 31.9 (1.1) 0.91 (0.01) 1.10 (0.03) 4.58 (0.35) 3.16 (0.35) 1517 (147)
Ucp2KO 32.0 (0.6) 0.91 (0.01) 1.10 (0.02) 4.63 (0.25) 2.52 (0.20) 1461 (124)
NntKO 33.0 (0.6) 0.92 (0.01) 1.07 (0.01) 5.52 (0.53) 2.57 (0.14) 1038 (52)
Ucp2KO/NntKO 32.2 (1.0) 0.91 (0.01) 1.09 (0.03) 5.38 (0.80) 2.60 (0.22) 1589 (232)
Values are means (±SEM) of n=11/12 mice per group. ANOVA showed no signiﬁcant difference between genotypes.
Fig. 4. Proton leak kinetics were measured in mouse kidney mitochondria from WT
(open square), Ucp2KO (light grey circle), NntKO (dark grey diamond) or Ucp2KO/
NntKO (closed triangle) mice after 1.5 min incubation with substrate (4 mM succinate).
The results are the means±SEM of 7 experiments, each performed in duplicate.
Respiration rates at a common driving force of 174 mV (inset) were not signiﬁcantly
different by ANOVA.
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in Fig. 3a, the effect of NNTablation on glucose tolerance was repeated
in a Ucp2KO background (Fig. 3d). Our results show that NNT ablation
signiﬁcantly reduced glucose tolerance despite the absence of UCP2,
showing that the presence of UCP2 is not required for the glucose
intolerant phenotype to be observed in NntKO mice, that is, UCP2 is
not a mediator of glucose homeostasis dysregulation in NntKO mice.
3.3. Energy balance in the double NNT and UCP2 knockout model
To assess whether there was any dysregulation of energy balance in
the double NNTand UCP2 knockout model, metabolic parameters were
assessed over a 72 h period (Table 1). No signiﬁcant differences were
seen in any of the parametersmeasured. However, ablation ofNnt alone
tended to decrease locomotor activity (although this result didnot reach
statistical signiﬁcance). Interestingly, locomotor activity was restored in
the double knockout, hinting at a UCP2-mediated, NntKO locomotor
phenotype. Further work is needed to follow up this intriguing ﬁnding.
3.4. Assessment of proton leak in kidney mitochondria isolated from the
double NNT and UCP2 knockout model
Kidneymitochondriawere used as an abundant source ofmitochon-
dria containing both UCP2 and NNT to test whether ablation of Nnt led,
as the hypothesis suggests, to a UCP2-dependent endogenous increase
inmitochondrial proton conductance. To look for endogenous activation
of UCP2, proton leak kinetics were measured in kidney mitochondria
isolated from mice of the four genotypes generated in the double NNT
and UCP2 knockout model (Fig. 4). After 1.5 min incubation with
substrate, no signiﬁcant difference in proton conductance was seen
between the four genotypes tested. This suggests that, at least in isolated
kidneymitochondria, absence of NNT does not promote an endogenous
increase in proton leak either through UCP2 or through other pathways
in the absence of UCP2.
4. Discussion
In this paperwedescribe theuse of a doubleNNTandUCP2knockout
mouse model to examine the possible contribution of activation of
mitochondrial proton leak through UCP2 to the poor peripheral glucose
uptake phenotype seen in NntKO mice compared to their WT siblings.
The principal ﬁndings of this paper are as follows. First, we were able to
replicate the published observations [33,35] that ablation of Nnt alone
leads to poorer glucose tolerance. Second, we were unable to replicate
the published observation [21] that ablation of Ucp2 alone leads to
improved glucose tolerance. Third, we ﬁnd that glucose tolerance is
similar inNntKOmicewhether or not UCP2 is present, showing that the
NntKO glucose intolerance phenotype, at least in our experiments, is not
mediated by UCP2. In addition, we ﬁnd that the different genotypes
show no signiﬁcant differences in energy balance.
In mitochondria isolated from the kidneys of these mice, we ﬁnd
UCP2 expression (∼7 ng UCP2 per μgmitochondrial protein— data not
shown) to be similar to that in rat kidney mitochondria [40]. We also
ﬁnd expression of NNT [41]. However, endogenous proton conduc-
tance is not different from WT in mitochondria from NntKO mice, asexpected (N Parker, unpublished observations). Nor is it different from
WT in kidney mitochondria from Ucp2KO mice, similar to the result
obtained for endogenous proton conductance in skeletal muscle
mitochondria from Ucp3KO mice [11]. Most importantly, endogenous
proton conductance in mitochondria from double Ucp2KO/NntKO
mice is not different from WT or from NntKO, showing that UCP2 is
not endogenously activated in isolated kidneymitochondria under our
incubation conditions when NNT is ablated.
We did not replicate the phenotype of improved glucose tolerance
in Ucp2KO mice reported in [21], despite a large cohort (31 mice per
group) and the clear presence of UCP2 in the WT pancreas (Fig. 2c).
Loss of the Ucp2KO phenotype of improved peripheral glucose
tolerance has also been seen by others when the Ucp2KO mutation
is backcrossed away from a mixed 129/Sv×C57Bl/6 background [42].
However, acute UCP2 knockdown by RNAi in INS-1E insulinoma cells
does altermitochondrial coupling efﬁciency and insulin secretion [27],
supporting the conclusions in [21]. This could suggest that either there
are strain-dependent ﬂuctuations in UCP2 function or could suggest
that the chronic ablation of UCP2 triggers an unknown, strain-
dependent compensatory mechanism. Similarly, while it was shown
that ablation of NNT in a mixed strain (shown here) or a strain other
than C57Bl/6 [33,35] caused a decrease in glucose tolerance,
reciprocal correction of the Nnt gene locus in C57Bl/6 mice does not
always lead to improvement in glucose tolerance [35]. Together, these
disparate results may highlight the strain dependency and multigenic
origin of the diabetic response, and suggest that the absence of UCP2
or presence of NNT can improve insulin secretion by pancreatic beta
cells under some circumstances, but not under others, depending on
factors yet to be identiﬁed.
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secretion between WT and NNT knockdown in the pancreatic beta cell
line, MIN6. This difference was normalised by tolbutamide, suggesting
that action of NNT occurs prior to KATP channel closure. In NntKO
pancreatic islets, ATP content was shown not to rise in response to
elevated glucose, suggesting that the role of NNT in the regulation of
insulin release is via a mechanism that affects ATP synthesis, directly or
indirectly. While the uncoupling of mitochondrial substrate oxidation
from ADP phosphorylation remains a candidate, increased proton leak
into the mitochondrial matrix catalysed speciﬁcally by UCP2 does not
seem to be the cause. It is noteworthy that mutations in other enzymes
that lead to a decrease in the ATP/ADP ratio in beta cells result in a
phenotype of reduced insulin secretion and impaired peripheral glucose
uptake. For example, mutant forms of glucokinase [43,44], or inhibition
of this enzyme [45] can lead to a severe diabetic phenotype, thought to
be caused by changes in the ATP/ADP ratio. NNTcatalyses the oxidation
of NADHwhenmitochondrial membrane potential is high. It is possible
that, in a ﬁnely tuned system (the pancreatic beta cell mitochondrion),
increased levels of NADH per oxidised glucose molecule in the NntKO
may inhibit the dehydrogenases of the tricarboxylic acid cycle, providing
a negative feedback signal and reducing ATP synthesis. By casting doubt
on the role of UCP2 in glucose dysregulation in NNTablated animals, we
open many other avenues to explore.
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